Market Data 
Markets
Replies to post #111085 on Biotech Values
The simple answer is that it’s easier to design a safe and effective non-nuke than a safe and effective nuke. The former merely has to bind to the HCV polymerase, while the latter has to “trick” the polymerase into thinking it’s a bona fide HCV nuke rather than an impostor.
AI
